Announcements Trials

Browse Landscape

Phase

Phase 3 4 Phase 2 4 Phase 1/2 3 Phase 1 2

Sponsor

Interventions

Cisplatin 12 Magnetic Resonance Spectroscopy 10 Specimen Handling 9 Gemcitabine 9 Carboplatin 9 pembrolizumab 8 Pemetrexed 8 atezolizumab 7 Radiotherapy, Intensity-Modulated 5 Platinum 5 Paclitaxel 5 Nivolumab 5 Immunoglobulin G 5 Doxorubicin 5 Docetaxel 5 Disulfides 5 Bevacizumab 5 130-nm albumin-bound paclitaxel 5 1,2-diaminocyclohexaneplatinum II citrate 5 Cetuximab 4 Biopsy 4 Temozolomide 3 Rituximab 3 Dexamethasone 3 (225)Ac-DOTA-c(RGDyK) 3 venetoclax 2 pegfilgrastim 2 merphos 2 liposomal doxorubicin 2 durvalumab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

0 trials

Recent Start date Enrollment

Phase 2/3 × abiraterone × 30 days × Clear all

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡